Violeta Catalá
Research Subjects
Violeta Catalá has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Joan Carles Vilanova
University of Girona
3 shared publications - Alexander Daniel Jacques Baur
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Klinik für Radiologie, Augustenburger Platz 1, 13353, Berlin, Germany.
1 shared publication - Amita Shukla-Dave
Department of Medical Physics Memorial Sloan Kettering Cancer Center New York New York USA
1 shared publication - Andreas G. Wibmer
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
1 shared publication - Angelique W. Levi
Yale New Haven Hospital, New Haven, CT
1 shared publication C. Brú
Clinic Hospital
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by XMLink in The World Journal of Men's Health
- Vol. 42 (3) , 660-661
The Need of Systematic Biopsies for the Appropriate Management of Localized Prostate Cancer
Morote J, et al. World J Mens Health. 2024 Mar;42:e38. https://doi.org/10.5534/wjmh.230331
- 1 January 2024
- Published by XMLink in The World Journal of Men's Health
- Vol. 42 (3) , 660-661
Open AccessThe Need of Systematic Biopsies for the Appropriate Management of Localized Prostate Cancer
Morote J, et al. World J Mens Health. 2024 Mar;42:e38. https://doi.org/10.5534/wjmh.230331
- Open Access
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer
Background: To develop an international, multi-site nomogram for side-specific prediction of extraprostatic extension (EPE) of prostate cancer based on clinical, biopsy, and magnetic resonance imaging- (MRI) derived data. Methods: Ten institutions from the USA and Europe contributed clinical and side-specific biopsy and MRI variables of consecutive patients who underwent prostatectomy. A logistic regression model was used to develop a nomogram for predicting side-specific EPE on prostatectomy specimens. The performance of the statistical model was evaluated by bootstrap resampling and cross validation and compared with the performance of benchmark models that do not incorporate MRI findings. Results: Data from 840 patients were analyzed; pathologic EPE was found in 320/840 (31.8%). The nomogram model included patient age, prostate-specific antigen density, side-specific biopsy data (i.e., Gleason grade group, percent positive cores, tumor extent), and side-specific MRI features (i.e., presence of a PI-RADSv2 4 or 5 lesion, level of suspicion for EPE, length of capsular contact). The area under the receiver operating characteristic curve of the new, MRI-inclusive model (0.828, 95% confidence limits: 0.805, 0.852) was significantly higher than that of any of the benchmark models (p < 0.001 for all). Conclusions: In an international, multi-site study, we developed an MRI-inclusive nomogram for the side-specific prediction of EPE of prostate cancer that demonstrated significantly greater accuracy than clinical benchmark models.
Open AccessInternational Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer
Background: To develop an international, multi-site nomogram for side-specific prediction of extraprostatic extension (EPE) of prostate cancer based on clinical, biopsy, and magnetic resonance imaging- (MRI) derived data. Methods: Ten institutions from the USA and Europe contributed clinical and side-specific biopsy and MRI variables of consecutive patients who underwent prostatectomy. A logistic regression model was used to develop a nomogram for predicting side-specific EPE on prostatectomy specimens. The performance of the statistical model was evaluated by bootstrap resampling and cross validation and compared with the performance of benchmark models that do not incorporate MRI findings. Results: Data from 840 patients were analyzed; pathologic EPE was found in 320/840 (31.8%). The nomogram model included patient age, prostate-specific antigen density, side-specific biopsy data (i.e., Gleason grade group, percent positive cores, tumor extent), and side-specific MRI features (i.e., presence of a PI-RADSv2 4 or 5 lesion, level of suspicion for EPE, length of capsular contact). The area under the receiver operating characteristic curve of the new, MRI-inclusive model (0.828, 95% confidence limits: 0.805, 0.852) was significantly higher than that of any of the benchmark models (p < 0.001 for all). Conclusions: In an international, multi-site study, we developed an MRI-inclusive nomogram for the side-specific prediction of EPE of prostate cancer that demonstrated significantly greater accuracy than clinical benchmark models.
- 13 July 2017
- Published by Springer Nature
- p. 115-142
Prostate Cancer and MRI: Local Staging
- 1 March 2017
- Published by Elsevier in Radiologia
- Vol. 59 (2) , 94-99
La resonancia magnética en el nuevo paradigma del diagnóstico del cáncer de próstata
- 1 March 2017
- Published by Elsevier in Radiologia
- Vol. 59 (2) , 94-99
La resonancia magnética en el nuevo paradigma del diagnóstico del cáncer de próstata
- 1 November 2003
- Published by Springer Nature in European Radiology
- Vol. 13 (S3) , N70-N78
Characterization of focal liver lesions with contrast-enhanced ultrasound
- 1 November 2003
- Published by Springer Nature in European Radiology
- Vol. 13 (S3) , N70-N78
Characterization of focal liver lesions with contrast-enhanced ultrasound